- Price
- $20.86
- Day
- +0.43%
- Mkt Cap
- $1.54B
- 52W Range
- $16.52 – $25.15
- Volume
- 564.5K
- Beta
- 0.34
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Supernus Pharmaceuticals NASDAQ: SUPN and Indivior Pharmaceuticals announced a proposed all-stock, tax-free merger of equals that would create a central nervous system-focused biopharmaceutical company with approximately $2.2 billion in pro forma trailing 12-month net revenue as of June 30, 2026.
Read full article
Dimensional Fund Advisors LP grew its holdings in shares of Innoviva, Inc. (NASDAQ: INVA) by 1.7% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 4,436,427 shares of the biotechnology company's stock after acquiring an additional 76,026 shares during the period. Dimensional Fund Advisors LP owned
Read full article